<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/static_war/render/xsl/rss2.xsl" media="screen" type="text/xsl"?>
<rss version="2.0">
  <channel>
    <title>Warwick Innovations &#187; Spin-out companies (tag [Therapeutics])</title>
    <link>https://warwick.ac.uk/services/innovations/partnerships/spinouts/</link>
    <description>The latest from Warwick Innovations &#187; Spin-out companies (tag [Therapeutics])</description>
    <language>en-GB</language>
    <copyright>(C) 2026 University of Warwick</copyright>
    <lastBuildDate>Thu, 20 Nov 2025 09:46:15 GMT</lastBuildDate>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <generator>SiteBuilder2, University of Warwick, http://go.warwick.ac.uk/sitebuilder</generator>
    <category>AI &amp; Data</category>
    <category>Energy &amp; environment</category>
    <category>Engineering, Materials &amp; Manufacturing</category>
    <category>Medtech &amp; diagnostics</category>
    <category>Therapeutics</category>
    <category>Untagged</category>
    <item>
      <title>Lightcast Discovery</title>
      <link>https://www.lightcast.bio/</link>
      <description>&lt;div class="news-thumbnail" style="float: left; margin-right: 10px; margin-bottom: 5px;"&gt;&lt;img class="thumbnail" width="100" height="100" src="https://warwick.ac.uk/sitebuilder2/file/services/innovations/partnerships/spinouts?sbrPage=%2Fservices%2Finnovations%2Fpartnerships%2Fspinouts&amp;newsItem=8a1785d78dc1dfe9018dd140b2b851ef" alt="image"&gt;&lt;/div&gt;&lt;p&gt;Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. &lt;/p&gt;</description>
      <category>Medtech &amp; diagnostics</category>
      <category>Therapeutics</category>
      <pubDate>Thu, 22 Feb 2024 14:38:14 GMT</pubDate>
      <guid isPermaLink="false">8a1785d78dc1dfe9018dd140b2b851ef</guid>
    </item>
    <item>
      <title>Tangent Reprofiling/Valiseek</title>
      <link>https://www.valirx.com/collaborative-pipeline</link>
      <description>&lt;div class="news-thumbnail" style="float: left; margin-right: 10px; margin-bottom: 5px;"&gt;&lt;img class="thumbnail" width="100" height="100" src="https://warwick.ac.uk/sitebuilder2/file/services/innovations/partnerships/spinouts?sbrPage=%2Fservices%2Finnovations%2Fpartnerships%2Fspinouts&amp;newsItem=8a1785d78b5c3c92018b819693f547eb" alt="image"&gt;&lt;/div&gt;&lt;p&gt;ValiSeek is ValiRx's Joint Venture Company, formed with Tangent Reprofiling Limited to rapidly progress VAL401 through development. VAL401 is in development for Pancreatic ductal adenocarcinoma.&lt;/p&gt;</description>
      <category>Therapeutics</category>
      <pubDate>Mon, 30 Oct 2023 17:16:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d78b5c3c92018b819693f547eb</guid>
    </item>
    <item>
      <title>NeuroSolutions</title>
      <link>https://nsolns.com/</link>
      <description>&lt;div class="news-thumbnail" style="float: left; margin-right: 10px; margin-bottom: 5px;"&gt;&lt;img class="thumbnail" width="100" height="100" src="https://warwick.ac.uk/sitebuilder2/file/services/innovations/partnerships/spinouts?sbrPage=%2Fservices%2Finnovations%2Fpartnerships%2Fspinouts&amp;newsItem=8a1785d78dc1dfe9018dd148121451f9" alt="image"&gt;&lt;/div&gt;&lt;p&gt;NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.&lt;/p&gt;</description>
      <category>Medtech &amp; diagnostics</category>
      <category>Therapeutics</category>
      <pubDate>Tue, 09 Aug 2022 08:45:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d78dc1dfe9018dd148121451f9</guid>
    </item>
  </channel>
</rss>
